Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
sCiEnTiFiC proGrAMME<br />
Sunday 13 May 2012<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 180 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
TEACHING LECTURE<br />
ModEls For sECondAry CAnCEr indUCTion AT rAdioThErApy dosE. An<br />
UpdATE<br />
08:30 - 09:10 • Room 116<br />
ChaiR: J. Cosset (France)<br />
08:30 > Models for secondary cancer induction at radiotherapy dose.<br />
An update<br />
SPEaKER: U. Schneider (Switzerland) SP-0576<br />
TEACHING LECTURE<br />
whAT is A sTEM CEll And why shoUld i CArE?<br />
08:30 - 09:10 • Room 120-121<br />
ChaiR: TBC<br />
08:30 > What is a stem cell and why should I care<br />
SPEaKER: M. Vooijs (The Netherlands) SP-0577<br />
TEACHING LECTURE<br />
rTT rEsponsibiliTiEs And inVolVEMEnT in rEsEArCh<br />
08:30 - 09:10 • Room 118-119<br />
ChaiR: A. Vaandering (Belgium)<br />
08:30 > RTT responsibilities and involvement in research<br />
Speaker TBC SP-0578<br />
SYMPOSIUM<br />
CUrrEnT prACTiCE And ConTroVErsiEs: brAin TUMoUrs<br />
09:15 - 10:30 • Room 112<br />
ChaiR: C. Belka (Germany)<br />
CO-ChaiR: F. Grillo Ruggieri (Italy)<br />
09:15 > Combination of targeted drugs with radioatherapy in<br />
gliobastoma = from mechanisms to therapy<br />
SPEaKER: E. Moyal-Cohen-Jonathan (France) SP-0579<br />
Sunday 13 May 2012<br />
abS. numbER<br />
09:40 > Low grade gliomas / treatment sequence<br />
(current practice and future trends)<br />
SPEaKER: R. Kortmann (Germany) SP-0580<br />
10:05 > Treating brain metastases: current approaches and controversies<br />
SPEaKER: G. Minniti (Italy) SP-0581<br />
SYMPOSIUM<br />
prEdiCTion oF CoMplETE rEsponsE CAn EnhAnCE orGAn prEsErVATion<br />
in rECTAl CAnCEr<br />
lEaRning ObJECTivES:<br />
1. The audience will be able to incorporate clinical and imaging parameters in their<br />
decision to offer rectal cancer patients the possibility of <strong>org</strong>an saving procedures<br />
09:15 - 10:30 • Room 113-114<br />
ChaiR: C. Marijnen (The Netherlands)<br />
CO-ChaiR: L. Cerezo (Spain)<br />
09:15 > PCR: a subgroup of patients with better survival or a unsafe<br />
surrogate endpoint<br />
SPEaKER: V. Valentini (Italy) SP-0582<br />
09:33 > Diffusion MR prediction: standard or research<br />
SPEaKER: R. Beets-Tan (The Netherlands) SP-0583<br />
09:51 > PET-CT prediction of response of rectal cancer to neo-adjuvant<br />
therapy: standard or research?<br />
SPEaKER: C. Deroose (Belgium) SP-0584<br />
10:09 > Modelling response prediction on clinical and imaging evidences<br />
SPEaKER: G. Lammering (The Netherlands) SP-0585<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 181<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language